OTC : ALPMF

Astellas Pharma Inc.

$13.15 USD

$0.3 (2.33%)

Volume
990
Average Volume
4.01K
Market Capitalization
$23.56B
P/E Ratio
13.20
Dividend Yield
3.63%
Price Target
Year High
$17.85
Year Low
$9.34
Day High
—
Day Low
—
Payout Ratio
$0.47
Current Ratio
$1.17

ALPMF Estimated and Actual Revenue by Quarter

ALPMF Estimated and Actual EPS by Quarter

ALPMF Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-03-31 1 98.71B 103.23B 101.27B 56.38B 58.97B 57.85B
2026-12-31 2 116.81B 122.16B 119.85B 66.72B 69.78B 68.46B
2026-09-30 3 110.66B 115.73B 113.54B 63.21B 66.11B 64.85B
2026-06-30 4 108.84B 111.36B 110.06B 62.17B 63.61B 62.87B
2026-03-31 6 97.58B 105.05B 102.08B 55.74B 60.01B 58.31B
2025-12-31 6 95.74B 110.89B 105.04B 54.69B 63.34B 60B
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-03-31 1 32B 33.92B 33.09B 213.6B 223.39B 219.15B
2026-12-31 2 98.39B 104.3B 101.75B 252.78B 264.36B 259.35B
2026-09-30 3 97.97B 103.84B 101.3B 239.47B 250.44B 245.69B
2026-06-30 4 88.66B 93.98B 91.68B 235.53B 240.98B 238.17B
2026-03-31 6 53.62B 56.84B 55.45B 211.16B 227.34B 220.9B
2025-12-31 6 81.69B 83.98B 82.83B 207.17B 239.97B 227.3B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-03-31 1 498.38B 521.2B 511.33B 1 17.75492 18.82039 18.35959
2026-12-31 2 589.78B 616.8B 605.11B 1 54.60103 57.87765 56.46056
2026-09-30 3 558.73B 584.32B 573.25B 1 54.3627 57.62503 56.21412
2026-06-30 4 549.55B 562.26B 555.7B 1 49.19857 52.15099 50.87411
2026-03-31 6 492.69B 530.42B 515.4B 1 29.75541 31.54104 30.76878
2025-12-31 6 483.38B 559.91B 530.34B 1 45.33228 46.59959 45.96593